Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tranzyme, Inc.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 to 80 years of age inclusive
Type 1 or type 2 diabetes mellitus
History of symptoms of gastroparesis for at least 3 months leading up to the Screening Visit
Documented delayed gastric emptying
Upper gastrointestinal obstruction ruled out by endoscopy or barium scan
Concomitant medications must be stable for at least 2 weeks leading up to the Screening visit and must be maintained during the study.
Females of child-bearing potential must have a negative serum pregnancy test and use (and agree to continue to use throughout the study) an acceptable form of contraception
You may not be if
Gastrectomy, bariatric surgery, fundoplication or vagotomy/pyloroplasty
Has had or plans to have endoscopic pyloric injections of botulinum toxin within 6 months prior to the Screening Visit or during the study
NG, PEG or PEJ feeding tube or inpatient hospitalization for gastroparesis within 2 weeks prior to the Screening Visit
Required parenteral nutrition for treatment of gastroparesis within 2 months prior to the Screening Visit
Active gastric pacemaker within 3 months prior to the Screening Visit
Clareo Health | Diabetic Gastroparesis Efficacy/Safety Study of TZP-102
